Camargo Appoints COO
Camargo Pharmaceuticals appoints a veteran health executive as new COO.
Jim Beach, a veteran health care executive, has been named chief operating officer for Camargo Pharmaceutical Services, a drug- development organization specializing in the 505(b)(2) approval pathway.
Prior to joining Camargo, Beach had been vice-president of marketing and product management for scientific products for Cardinal Health, vice-president of market insights and a member of the US management board for Ethicon Endo-Surgery, and leader of the global product company program for GE Healthcare.
Source: Camargo Pharmaceutical Services
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
